[19980326]97-917_疾病资助和NIH优先设置.pdf

上传人:任我行 文档编号:14652 上传时间:2022-06-24 发布时间:1998-03-30 格式:PDF 页数:6 大小:39.48KB
下载 相关 举报
[19980326]97-917_疾病资助和NIH优先设置.pdf_第1页
第1页 / 共6页
[19980326]97-917_疾病资助和NIH优先设置.pdf_第2页
第2页 / 共6页
[19980326]97-917_疾病资助和NIH优先设置.pdf_第3页
第3页 / 共6页
[19980326]97-917_疾病资助和NIH优先设置.pdf_第4页
第4页 / 共6页
[19980326]97-917_疾病资助和NIH优先设置.pdf_第5页
第5页 / 共6页
点击查看更多>>
资源描述

1、CRS Report 97-126, Federal R&D Funding Trends in Five Agencies: NSF, NASA, NIST,1DOE (Civilian) and NOAA, coordinated by Michael E. Davey.CRS Report 95-96, The National Institutes of Health: An Overview, by Pamela W. Smith.2Congressional Research Service The Library of CongressCRS Report for Congres

2、sReceived through the CRS Web97-917 STMUpdated March 26, 1998Disease Funding and NIH Priority SettingJudith A. JohnsonSpecialist in Life SciencesScience, Technology, and Medicine DivisionSummaryResearch at the National Institutes of Health (NIH) has strong political support, buta heated debate rages

3、 over the allocation of NIH funds among various diseases. NIHcontends that decisions are made based on scientific opportunity while critics of the NIHprocess charge that spending often follows current politics and political correctness.The ongoing effort to balance the federal budget has reduced ove

4、rall federal researchand development (R&D) funding. Between FY1995 and FY1997 total civilian R&Ddeclined 4.1% in real terms. Although overall federal R&D spending is down over the1past several years, one sector of the federal R&D effort has been protected. Biomedicalresearch funding at the National

展开阅读全文
相关资源
猜你喜欢
相关搜索
资源标签

当前位置:首页 > 法规条令 > CRS 美国国会研究处报告